| |
| |
| |
| |
| |
| RB1; retinoblastoma 1 [KO: K06618] |
| RBL1; retinoblastoma-like 1 (p107) [KO: K04681] |
| RBL2; retinoblastoma-like 2 (p130) [KO: K16332] |
| ABL1; c-abl oncogene 1, non-receptor tyrosine kinase [KO: K06619] [EC: 2.7.10.2] |
| |
| |
| E2F1; E2F transcription factor 1 [KO: K06620] |
| E2F3; E2F transcription factor 3 [KO: K06620] |
| E2F2; E2F transcription factor 2 [KO: K09389] |
| E2F4; E2F transcription factor 4, p107/p130-binding [KO: K04682] |
| E2F5; E2F transcription factor 5, p130-binding [KO: K04682] |
| TFDP1; transcription factor Dp-1 [KO: K04683] |
| TFDP2; transcription factor Dp-2 (E2F dimerization partner 2) [KO: K09392] |
| |
| TGFB1; transforming growth factor, beta 1 [KO: K13375] |
| TGFB2; transforming growth factor, beta 2 [KO: K13376] |
| TGFB3; transforming growth factor, beta 3 [KO: K13377] |
| SMAD2; SMAD family member 2 [KO: K04500] |
| SMAD3; SMAD family member 3 [KO: K04500] |
| SMAD4; SMAD family member 4 [KO: K04501] |
| MYC; v-myc myelocytomatosis viral oncogene homolog (avian) [KO: K04377] |
| ZBTB17; zinc finger and BTB domain containing 17 [KO: K10500] |
| CDKN2A; cyclin-dependent kinase inhibitor 2A [KO: K06621] |
| CDKN2B; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) [KO: K04685] |
| CDKN2C; cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) [KO: K06622] |
| CDKN2D; cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) [KO: K06623] |
| CDKN1B; cyclin-dependent kinase inhibitor 1B (p27, Kip1) [KO: K06624] |
| CDKN1C; cyclin-dependent kinase inhibitor 1C (p57, Kip2) [KO: K09993] |
| CDKN1A; cyclin-dependent kinase inhibitor 1A (p21, Cip1) [KO: K06625] |
| |
| |
| |
| SKP1; S-phase kinase-associated protein 1 [KO: K03094] |
| |
| RBX1; ring-box 1, E3 ubiquitin protein ligase [KO: K03868] |
| SKP2; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase [KO: K03875] |
| |
| |
| CDC6; cell division cycle 6 [KO: K02213] |
| CDC45; cell division cycle 45 [KO: K06628] |
| |
| DBF4; DBF4 homolog (S. cerevisiae) [KO: K06629] |
| |
| |
| |
| |
| |
| |
| YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide [KO: K16197] |
| YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide [KO: K16197] |
| YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide [KO: K16197] |
| YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide [KO: K06630] |
| YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide [KO: K16198] |
| YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide [KO: K16198] |
| |
| |
| |
| PKMYT1; protein kinase, membrane associated tyrosine/threonine 1 [KO: K06633] [EC: 2.7.11.1] |
| |
| |
| ANAPC1; anaphase promoting complex subunit 1 [KO: K03348] |
| ANAPC2; anaphase promoting complex subunit 2 [KO: K03349] |
| CDC27; cell division cycle 27 [KO: K03350] |
| ANAPC4; anaphase promoting complex subunit 4 [KO: K03351] |
| ANAPC5; anaphase promoting complex subunit 5 [KO: K03352] |
| CDC16; cell division cycle 16 [KO: K03353] |
| ANAPC7; anaphase promoting complex subunit 7 [KO: K03354] |
| CDC23; cell division cycle 23 [KO: K03355] |
| ANAPC10; anaphase promoting complex subunit 10 [KO: K03357] |
| ANAPC11; anaphase promoting complex subunit 11 [KO: K03358] |
| CDC26; cell division cycle 26 [KO: K03359] |
| ANAPC13; anaphase promoting complex subunit 13 [KO: K12456] |
| CDC20; cell division cycle 20 [KO: K03363] |
| PTTG1; pituitary tumor-transforming 1 [KO: K06635] |
| PTTG2; pituitary tumor-transforming 2 [KO: K06635] |
| ESPL1; extra spindle pole bodies homolog 1 (S. cerevisiae) [KO: K02365] [EC: 3.4.22.49] |
| SMC1A; structural maintenance of chromosomes 1A [KO: K06636] |
| SMC1B; structural maintenance of chromosomes 1B [KO: K06636] |
| SMC3; structural maintenance of chromosomes 3 [KO: K06669] |
| STAG2; stromal antigen 2 [KO: K06671] |
| STAG1; stromal antigen 1 [KO: K06671] |
| RAD21; RAD21 homolog (S. pombe) [KO: K06670] |
| |
| BUB1; BUB1 mitotic checkpoint serine/threonine kinase [KO: K02178] [EC: 2.7.11.1] |
| BUB3; BUB3 mitotic checkpoint protein [KO: K02180] |
| BUB1B; BUB1 mitotic checkpoint serine/threonine kinase B [KO: K06637] [EC: 2.7.11.1] |
| MAD1L1; MAD1 mitotic arrest deficient-like 1 (yeast) [KO: K06638] |
| MAD2L1; MAD2 mitotic arrest deficient-like 1 (yeast) [KO: K02537] |
| MAD2L2; MAD2 mitotic arrest deficient-like 2 (yeast) [KO: K13728] |
| FZR1; fizzy/cell division cycle 20 related 1 (Drosophila) [KO: K03364] |
| |
| |
| |
| |
| TP53; tumor protein p53 [KO: K04451] |
| |
| |
| |
| |
| PRKDC; protein kinase, DNA-activated, catalytic polypeptide [KO: K06642] [EC: 2.7.11.1] |
| MDM2; MDM2 oncogene, E3 ubiquitin protein ligase [KO: K06643] [EC: 6.3.2.19] |
| GADD45A; growth arrest and DNA-damage-inducible, alpha [KO: K04402] |
| GADD45B; growth arrest and DNA-damage-inducible, beta [KO: K04402] |
| GADD45G; growth arrest and DNA-damage-inducible, gamma [KO: K04402] |
| PCNA; proliferating cell nuclear antigen [KO: K04802] |
| |
| |
| ORC1; origin recognition complex, subunit 1 [KO: K02603] |
| ORC2; origin recognition complex, subunit 2 [KO: K02604] |
| ORC3; origin recognition complex, subunit 3 [KO: K02605] |
| ORC4; origin recognition complex, subunit 4 [KO: K02606] |
| ORC5; origin recognition complex, subunit 5 [KO: K02607] |
| ORC6; origin recognition complex, subunit 6 [KO: K02608] |
| MCM2; minichromosome maintenance complex component 2 [KO: K02540] [EC: 3.6.4.12] |
| MCM3; minichromosome maintenance complex component 3 [KO: K02541] [EC: 3.6.4.12] |
| MCM4; minichromosome maintenance complex component 4 [KO: K02212] [EC: 3.6.4.12] |
| MCM5; minichromosome maintenance complex component 5 [KO: K02209] [EC: 3.6.4.12] |
| MCM6; minichromosome maintenance complex component 6 [KO: K02542] [EC: 3.6.4.12] |
| MCM7; minichromosome maintenance complex component 7 [KO: K02210] [EC: 3.6.4.12] |